The prognostic value of TIM-3 differs among the breast cancer subtypes, being associated with a poor prognosis in the luminal A and luminal B carcinomas, whereas a better prognostic outcome has been reported in triple-negative carcinomas. Here, HAVCR2 is linked to breast cancer.